Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	54,991	57,463	61,462	78,767	97,546	174,747
Market Cap Growth	-7.41%	-6.51%	-21.97%	-19.25%	-44.18%	62.58%
Enterprise Value	33,696	37,707	39,202	46,863	48,995	136,075
Last Close Price	6230.00	6510.00	6845.95	8533.50	10440.22	18480.13
PE Ratio	113.27	78.50	21.09	-	9.60	11.21
PS Ratio	0.71	0.75	0.82	0.88	0.93	2.17
PB Ratio	0.64	0.67	0.71	0.92	1.10	2.28
P/TBV Ratio	0.66	0.69	0.74	0.96	1.17	2.36
P/FCF Ratio	12.59	13.16	-	-	-	21.89
P/OCF Ratio	11.55	12.07	-	84.64	-	19.60
EV/Sales Ratio	0.44	0.49	0.52	0.52	0.47	1.69
EV/EBITDA Ratio	18.09	20.33	16.92	12.39	4.80	14.51
EV/EBIT Ratio	48.19	54.52	41.15	18.79	5.33	18.26
EV/FCF Ratio	7.72	8.64	-	-	-	17.04
Debt / Equity Ratio	0.14	0.14	0.04	0.08	0.20	0.21
Debt / EBITDA Ratio	6.24	6.24	1.59	1.78	1.74	1.68
Debt / FCF Ratio	2.65	2.65	-	-	-	1.97
Net Debt / Equity Ratio	-0.27	-0.27	-0.23	-0.34	-0.42	-0.78
Net Debt / EBITDA Ratio	-12.47	-12.47	-8.56	-7.59	-3.67	-6.35
Net Debt / FCF Ratio	-5.30	-5.30	4.26	1920.12	7.78	-7.46
Asset Turnover	0.70	0.70	0.70	0.72	0.77	0.75
Inventory Turnover	2.35	2.35	2.35	3.57	5.15	4.63
Quick Ratio	1.37	1.37	2.30	1.77	1.35	1.44
Current Ratio	2.28	2.28	4.39	2.60	1.88	1.77
Return on Equity (ROE)	0.66%	0.66%	3.65%	-2.67%	12.78%	23.03%
Return on Assets (ROA)	0.39%	0.39%	0.55%	1.25%	4.23%	4.34%
Return on Invested Capital (ROIC)	0.70%	0.69%	1.36%	4.63%	20.31%	19.66%
Return on Capital Employed (ROCE)	0.80%	0.80%	1.10%	2.90%	10.30%	9.70%
Earnings Yield	1.33%	1.27%	4.74%	-0.15%	10.41%	8.92%
FCF Yield	7.94%	7.60%	-7.58%	-0.02%	-4.94%	4.57%
Payout Ratio	115.25%	115.25%	28.70%	-	7.86%	4.93%
Buyback Yield / Dilution	-53.00%	-53.00%	2.96%	19.46%	-23.72%	0.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.